<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2026-9-2-9-14</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-541</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛУЧЕВАЯ ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RADIOTHERAPY</subject></subj-group></article-categories><title-group><article-title>Реализация протоколов гарантии качества в отделении радиотерапии НМИЦ онкологии им. Н.Н. Блохина</article-title><trans-title-group xml:lang="en"><trans-title>Implementation of Quality Assurance Protocols in the Radiotherapy Department of N.N. Blokhin National Medical Research Center of Oncology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4944-4035</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p><p>119048, Москва, ул. Трубецкая, 8, корп. 2</p></bio><bio xml:lang="en"><p>Marina V. Chernykh</p><p>24 Kashirskoye Highway, Moscow, 115478</p><p>8 Trubetskaya str., Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-6250-2957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронова Олеся Анатольевна</p><p>115478, Москва, Каширское шоссе, 24</p><p>+7(925) 195-16-07</p></bio><bio xml:lang="en"><p>Olesia A. Mironova</p><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><email xlink:type="simple">oa.mironova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3028-7578</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Valery A. Ivanov</p><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4721-6426</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уваров</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Uvarov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Andrey S. Uvarov</p><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0603-2206</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>В. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>V. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>127006, Москва, ул. Долгоруковская, 4</p></bio><bio xml:lang="en"><p>Vasili D. Chernykh</p><p>4 Dolgorukovskaya str., Moscow, 127006</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0493-1166</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стилиди</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Stilidi</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Ivan S. Stilidi</p><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава России; Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology; I.M. Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Российский университет медицины Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian University of Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>14</day><month>06</month><year>2026</year></pub-date><volume>9</volume><issue>2</issue><fpage>9</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Черных М.В., Миронова О.А., Иванов В.А., Уваров А.С., Черных В.Д., Стилиди И.С., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Черных М.В., Миронова О.А., Иванов В.А., Уваров А.С., Черных В.Д., Стилиди И.С.</copyright-holder><copyright-holder xml:lang="en">Chernykh M.V., Mironova O.A., Ivanov V.A., Uvarov A.S., Chernykh V.D., Stilidi I.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/541">https://www.oncoradjournal.ru/jour/article/view/541</self-uri><abstract><sec><title>Цель</title><p>Цель: Разработка и внедрение клинических протоколов лучевой терапии в НМИЦ онкологии им. Н.Н. Блохина для стандартизации всех этапов лечебного процесса и повышения качества радиотерапевтической помощи.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: В рамках федеральной программы «Борьба с онкологическими заболеваниями» проведено масштабное обновление оборудования, что потребовало пересмотра подходов к планированию лечения и подготовки персонала. Разработанные протоколы охватывают весь цикл лучевой терапии — от КТ-топометрии до проведения облучения — и включают детализированные рекомендации по определению объемов облучения, органов риска, дозовых ограничений и критериев качества планов. На основании международных стандартов (IAEA, ICRU, RTOG, TG 263) обеспечена унификация номенклатуры структур, цветовой схемы и критериев оценки дозиметрических планов.</p></sec><sec><title>Результаты</title><p>Результаты: Внедрение 157 клинических протоколов позволило ускорить процесс планирования, снизить вариабельность между специалистами и повысить воспроизводимость результатов лечения. Стандартизация рабочих процессов способствовала снижению вероятности ошибок, упрощению обучения новых сотрудников и созданию условий для автоматизации ряда процедур. Внедрение клинических протоколов в практику радиационной онкологии повысило качество и безопасность лучевой терапии, улучшив согласованность работы коллектива и клинические результаты лечения пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: To develop and implement clinical radiotherapy protocols at the aimed at standardizing all stages of the treatment process and improving the quality of radiotherapy care.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: As part of the federal program “Fight Against Oncological Diseases,” a large-scale equipment upgrade was carried out, requiring revision of treatment planning approaches and staff training. The developed protocols cover the entire radiotherapy workflow — from CT simulation to treatment delivery — and include detailed recommendations for target volume delineation, organs-at-risk definition, dose constraints, and treatment plan quality criteria. Based on international standards (IAEA, ICRU, RTOG, TG 263), unified structure nomenclature, color coding, and dosimetric evaluation criteria were implemented.</p></sec><sec><title>Results</title><p>Results: The implementation of 157 clinical protocols enabled acceleration of the treatment planning process, reduction of inter-observer variability, and improvement in the reproducibility of treatment outcomes. Standardization of clinical workflows contributed to reducing the probability of errors, simplifying the training of new staff members, and creating conditions for the automation of several procedures. The introduction of clinical protocols into radiation oncology practice improved the quality and safety of radiotherapy, enhanced team coordination, and contributed to better clinical outcomes for patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>лучевая терапия</kwd><kwd>клинические протоколы</kwd><kwd>стандартизация</kwd><kwd>программа гарантии качества</kwd><kwd>органы риска</kwd><kwd>планирование облучения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>radiation therapy</kwd><kwd>clinical protocols</kwd><kwd>standardization</kwd><kwd>quality assurance program</kwd><kwd>organs at risk</kwd><kwd>treatment planning</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный проект «Борьба с онкологическими заболеваниями» за период 2019–2024 годов, 2024</mixed-citation><mixed-citation xml:lang="en">The Federal Project “Fighting Cancer” for the period 2019-2024, 2024 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Transition from 2-D radiotherapy to 3-D conformal and intensity modulated radiotherapy IAEA-TECDOC-1588, 2008</mixed-citation><mixed-citation xml:lang="en">Transition from 2-D radiotherapy to 3-D conformal and intensity modulated radiotherapy IAEA-TECDOC-1588, 2008</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Saiful Huq M, Fraass BA, Dunscombe PB, et al. The Report of Task Group 100 of the AAPM: Application of Risk Analysis Methods to Radiation Therapy Quality Management. Medical Physics. 2016; 43(7):4209-4262. https://doi.org/10.1118/1.4947547</mixed-citation><mixed-citation xml:lang="en">Saiful Huq M, Fraass BA, Dunscombe PB, et al. The Report of Task Group 100 of the AAPM: Application of Risk Analysis Methods to Radiation Therapy Quality Management. Medical Physics. 2016; 43(7):4209-4262. https://doi.org/10.1118/1.4947547</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства Здравоохранения Российской Федерации от 19 февраля 2021 года N 116н «Об утверждении Порядка оказания медицинской помощи взрослому населению при онкологических заболеваниях», 2021</mixed-citation><mixed-citation xml:lang="en">Order No. 116n of the Ministry of Health of the Russian Federation dated February 19, 2021, “On Approval of the Procedure for Providing Medical Care to Adults with Cancer”, 2021. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Safety Reports Series № 17 «Lessons learned from accidental exposures in radiotherapy» International Atomic Energy Agency, 2000.</mixed-citation><mixed-citation xml:lang="en">Safety Reports Series № 17 «Lessons learned from accidental expo­sures in radiotherapy» International Atomic Energy Agency, 2000.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Злокачественные опухоли: Практические рекомендации Российского общества клинической онкологии. Под ред. Моисеенко В.М. Общероссийская общественная организация «Российское общество клинической онкологии», 2024.</mixed-citation><mixed-citation xml:lang="en">Malignant Tumors: Practical Recommendations of the Russian Society of Clinical Oncology. Ed by Moiseenko VM. Moscow: Russian Society of Clinical Oncology, 2024. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">ICRU Report 83 Prescribing, Recording, and Reporting Photon-beam Intensity-modulated Radiation Therapy (IMRT). Journal of the ICRU. 2010;10(1). https://doi.org/10.1093/jicru/ndq001</mixed-citation><mixed-citation xml:lang="en">ICRU Report 83 Prescribing, Recording, and Reporting Photon-beam Intensity-modulated Radiation Therapy (IMRT). Journal of the ICRU. 2010;10(1). https://doi.org/ 10.1093/jicru/ndq001</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kachnic LA, Winter K, Myerson RJ. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiation Oncology Biol Phys. 2013; 86(1):27-33. https://doi.org/10.1016/j.ijrobp.2012.09.023</mixed-citation><mixed-citation xml:lang="en">Kachnic LA, Winter K, Myerson RJ. RTOG 0529: a phase 2 evalua­tion of dose-painted intensity modulated radiation therapy in com­bination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiation On­cology Biol Phys. 2013; 86(1):27-33. https://doi.org/10.1016/j.ijrobp.2012.09.023</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bradley JD, Hu Ch, Komaki R. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. . 2019;38(7). Journal of Clinical Oncology https://doi.org/10.1200/JCO.19.01162</mixed-citation><mixed-citation xml:lang="en">Bradley JD, Hu Ch, Komaki R. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. . 2019;38(7). Journal of Clinical Oncology https://doi.org/10.1200/JCO.19.01162</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bradley JD, Hu C, Komaki RR, et al. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. J Clin Oncol. 2020;38(7):706-714. https://doi.org/10.1200/JCO.19.01162.</mixed-citation><mixed-citation xml:lang="en">Bradley JD, Hu C, Komaki RR, et al. Long-Term Results of NRG Oncolo­gy RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. J Clin Oncol. 2020;38(7):706-714. https://doi.org/10.1200/JCO.19.01162.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hong TS, Moughan J, Garofalo MC, et al. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015;93(1):29-36. https://doi.org/10.1016/j.ijrobp.2015.05.005.</mixed-citation><mixed-citation xml:lang="en">Hong TS, Moughan J, Garofalo MC, et al. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Ther­apy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015;93(1):29-36. https://doi.org/10.1016/j.ijrobp.2015.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Standardizing Nomenclatures in Radiation Oncology The Report of AAPM Task Group 263, 2018</mixed-citation><mixed-citation xml:lang="en">Standardizing Nomenclatures in Radiation Oncology The Report of AAPM Task Group 263, 2018</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
